Filing Details

Accession Number:
0000899243-22-011432
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-03-17 17:14:49
Reporting Period:
2022-01-06
Accepted Time:
2022-03-17 17:14:49
Original Submission Date:
2022-01-25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1658551 Amylyx Pharmaceuticals Inc. AMLX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1543112 Ltd Investments Venture Morningside C/O Thc Management Services S.a.m.
3-5 Avenue Des Citronniers
Monaco O9 MC 98000
No No Yes No
1914583 Mvil, Llc C/O 22Nd Floor, Hang Lung Centre
2-20 Paterson St.
Causeway Bay, Hong Kong K3
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-11 10,415,650 $0.00 10,415,650 No 4 C Indirect See Footnotes
Common Stock Acquisiton 2022-01-11 263,158 $19.00 10,678,808 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnotes
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2022-01-11 1,409,035 $0.00 1,409,035 $0.00
Common Stock Series B Preferred Stock Disposition 2022-01-11 6,410,964 $0.00 6,410,964 $0.00
Common Stock Series C-1 Preferred Stock Disposition 2022-01-11 974,107 $0.00 974,107 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2022-01-11 1,621,544 $0.00 1,621,544 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the "Preferred Stock") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date.
  2. Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC ("MVIL LLC"), Morningside's wholly-owned subsidiary. Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC. Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC.
  3. The shares of Series C-2 Preferred Stock and the Common Stock received upon conversion of the C-2 Preferred Stock are held by MVIL LLC.